Virtual Conference: Antisense Oligonucleotides for Prion Disease with Anne Smith, Executive Director, Clinical Development at Ionis Pharmaceuticals
Tuesday, September 29, 2020 - 7:00pm

Join us virtually on Tuesday, September 29 at 7 pm Eastern to hear from Anne Smith, Executive Director, Clinical Development at Ionis Pharmaceuticals.

Anne Smith, PhD, is an Executive Director of Clinical Development at Ionis Pharmaceuticals, a California-based biotechnology company focused on RNA-targeting therapeutics. She is responsible for shepherding promising therapies from the research stage through clinical trials.  She specializes in neurology drug development and leads teams working in multiple disease areas. Anne is passionate about developing treatments for underserved patients and is thrilled to be leading Ionis’ prion development program. She will be presenting on antisense oligonucleotide targeting of PRNP mRNA as potential treatment for prion disease. 

Click here to register.